TIAA CREF Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $19.5M | Sell |
208,284
-127,409
| -38% | -$11.9M | 0.01% | 718 |
|
|
2018
Q4 | $24.5M | Sell |
335,693
-86,365
| -20% | -$6.3M | 0.02% | 581 |
|
|
2018
Q3 | $36.9M | Buy |
422,058
+245,463
| +139% | +$21.5M | 0.02% | 528 |
|
|
2018
Q2 | $17.4M | Sell |
176,595
-7,068
| -4% | -$696K | 0.01% | 813 |
|
|
2018
Q1 | $21.9M | Sell |
183,663
-71,653
| -28% | -$8.53M | 0.01% | 721 |
|
|
2017
Q4 | $32.4M | Buy |
255,316
+148,280
| +139% | +$18.8M | 0.02% | 576 |
|
|
2017
Q3 | $12.6M | Sell |
107,036
-401,816
| -79% | -$47.2M | 0.01% | 1009 |
|
|
2017
Q2 | $40.6M | Buy |
508,852
+383,214
| +305% | +$30.6M | 0.03% | 501 |
|
|
2017
Q1 | $6.44M | Sell |
125,638
-9,848
| -7% | -$505K | ﹤0.01% | 1423 |
|
|
2016
Q4 | $5.07M | Sell |
135,486
-78,714
| -37% | -$2.95M | ﹤0.01% | 1594 |
|
|
2016
Q3 | $14.5K | Buy |
214,200
+21,783
| +11% | +$1.48K | 0.01% | 915 |
|
|
2016
Q2 | $10.7M | Sell |
192,417
-1,788
| -0.9% | -$99.2K | 0.01% | 1032 |
|
|
2016
Q1 | $12.2M | Sell |
194,205
-6,582
| -3% | -$413K | 0.01% | 942 |
|
|
2015
Q4 | $18.9M | Sell |
200,787
-21,107
| -10% | -$1.99M | 0.01% | 775 |
|
|
2015
Q3 | $17.8M | Sell |
221,894
-190,888
| -46% | -$15.3M | 0.01% | 772 |
|
|
2015
Q2 | $49.5M | Buy |
412,782
+273,824
| +197% | +$32.8M | 0.04% | 486 |
|
|
2015
Q1 | $14.5M | Buy |
138,958
+6,836
| +5% | +$714K | 0.01% | 926 |
|
|
2014
Q4 | $12.8M | Buy |
132,122
+20,181
| +18% | +$1.96M | 0.01% | 960 |
|
|
2014
Q3 | $8.74M | Sell |
111,941
-51,260
| -31% | -$4M | 0.01% | 1184 |
|
|
2014
Q2 | $10.3M | Sell |
163,201
-87,933
| -35% | -$5.55M | 0.01% | 1137 |
|
|
2014
Q1 | $16.9M | Sell |
251,134
-4,470
| -2% | -$300K | 0.01% | 849 |
|
|
2013
Q4 | $16.4M | Sell |
255,604
-384
| -0.2% | -$24.7K | 0.01% | 874 |
|
|
2013
Q3 | $16.4M | Buy |
255,988
+13,553
| +6% | +$868K | 0.01% | 842 |
|
|
2013
Q2 | $7.52M | Buy |
+242,435
| New | +$7.52M | 0.01% | 1223 |
|